Wall Street Analysts Predict a 36.47% Upside in Select Medical (SEM): Here's What You Should Know
The mean of analysts' price targets for Select Medical (SEM) points to a 36.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Here's Why Select Medical (SEM) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Select Medical (SEM) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Select Medical Shares Down 20% Despite Q2 Earnings Beat
SEM beats Q2 EPS estimates on strong Rehab admissions and higher revenue per patient day. Yet, shares drop 20.4% post-earnings.
Should Value Investors Buy Select Medical (SEM) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Select Medical (SEM) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript
Select Medical Holdings Corporation (NYSE:SEM ) Q2 2025 Earnings Conference Call August 1, 2025 9:00 AM ET Company Participants Michael F. Malatesta - Executive VP & CFO Robert A.
Select Medical (SEM) Surpasses Q2 Earnings and Revenue Estimates
Select Medical (SEM) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.6 per share a year ago.
Select Medical: Despite A Change In The Regulatory Environment, This Prospect Is Worth Considering
Select Medical Holdings remains a soft 'buy' due to attractive valuation, organic growth, and solid top-line performance despite recent share price decline. Legislative changes pose risks, particularly from reduced Medicaid coverage, but only a small portion of revenue is exposed to this headwind. Recent results show revenue growth and improving profitability from continuing operations, though some metrics like EBITDA and adjusted cash flow have softened.
Why Select Medical (SEM) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Select Medical Expands Presence in Tennessee With Ballad Health Deal
SEM partners with Ballad Health to relocate and expand its Tri-Cities critical illness recovery hospital, boosting care access in Tennessee by being able to treat more patients grappling with serious illnesses.
Here's Why Select Medical (SEM) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
